JP2023512294A5 - - Google Patents
Info
- Publication number
- JP2023512294A5 JP2023512294A5 JP2022547055A JP2022547055A JP2023512294A5 JP 2023512294 A5 JP2023512294 A5 JP 2023512294A5 JP 2022547055 A JP2022547055 A JP 2022547055A JP 2022547055 A JP2022547055 A JP 2022547055A JP 2023512294 A5 JP2023512294 A5 JP 2023512294A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- sequence
- poxvirus
- fragments
- dna fragments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026033811A JP2026094336A (ja) | 2020-02-03 | 2026-03-04 | 天然ｄｎａまたは合成ｄｎａによって作製されたポックスウイルスベースのベクターおよびその使用法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062969628P | 2020-02-03 | 2020-02-03 | |
| US62/969,628 | 2020-02-03 | ||
| US202063113803P | 2020-11-13 | 2020-11-13 | |
| US63/113,803 | 2020-11-13 | ||
| PCT/US2021/016247 WO2021158565A2 (en) | 2020-02-03 | 2021-02-02 | Poxvirus-based vectors produced by natural or synthetic dna and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026033811A Division JP2026094336A (ja) | 2020-02-03 | 2026-03-04 | 天然ｄｎａまたは合成ｄｎａによって作製されたポックスウイルスベースのベクターおよびその使用法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023512294A JP2023512294A (ja) | 2023-03-24 |
| JP2023512294A5 true JP2023512294A5 (enExample) | 2024-02-09 |
Family
ID=77200801
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547055A Pending JP2023512294A (ja) | 2020-02-03 | 2021-02-02 | 天然ｄｎａまたは合成ｄｎａによって作製されたポックスウイルスベースのベクターおよびその使用法 |
| JP2026033811A Pending JP2026094336A (ja) | 2020-02-03 | 2026-03-04 | 天然ｄｎａまたは合成ｄｎａによって作製されたポックスウイルスベースのベクターおよびその使用法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026033811A Pending JP2026094336A (ja) | 2020-02-03 | 2026-03-04 | 天然ｄｎａまたは合成ｄｎａによって作製されたポックスウイルスベースのベクターおよびその使用法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4100514A4 (enExample) |
| JP (2) | JP2023512294A (enExample) |
| KR (1) | KR20220148823A (enExample) |
| CN (1) | CN115397998A (enExample) |
| AU (2) | AU2021217073A1 (enExample) |
| BR (1) | BR112022014738A2 (enExample) |
| CA (1) | CA3168836A1 (enExample) |
| IL (1) | IL294926A (enExample) |
| MX (1) | MX2022009200A (enExample) |
| WO (1) | WO2021158565A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3167052A1 (en) | 2020-02-14 | 2021-08-19 | Mary Jo Hauser | Vaccines and uses thereof to induce an immune response to sars-cov2 |
| EP4153228A4 (en) | 2020-05-17 | 2024-07-10 | City of Hope | CORONAVIRUS VACCINES BASED ON SYNTHETIC MODIFIED ANKARA VACCINE (SMVA) VIRUS |
| BR112023015467A2 (pt) | 2021-02-02 | 2023-10-10 | Geovax Inc | Vetor viral de vaccinia ankara recombinante modificado, métodos para aumentar uma resposta imunológica a um antígeno alvo em um paciente e para prevenir, tratar ou induzir uma resposta imunológica contra um antígeno alvo, e, composição farmacêutica |
| CN115433741A (zh) * | 2022-06-23 | 2022-12-06 | 广西大学 | 盖他病毒为载体表达报告蛋白的重组病毒的构建方法 |
| CN118240879A (zh) * | 2023-11-01 | 2024-06-25 | 上海市重大传染病和生物安全研究院 | 骨架质粒、重组质粒以及猴痘病毒颗粒和应用 |
| CN119506355B (zh) * | 2025-01-15 | 2025-10-17 | 中国人民解放军军事科学院军事医学研究院 | 一种用于重组痘病毒包装的载体系统及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3099330A1 (en) * | 2018-05-02 | 2019-11-07 | Tonix Pharma Holdings Limited | Synthetic chimeric vaccinia virus |
-
2021
- 2021-02-02 CN CN202180025623.2A patent/CN115397998A/zh active Pending
- 2021-02-02 EP EP21750239.2A patent/EP4100514A4/en active Pending
- 2021-02-02 BR BR112022014738A patent/BR112022014738A2/pt unknown
- 2021-02-02 AU AU2021217073A patent/AU2021217073A1/en active Pending
- 2021-02-02 KR KR1020227030182A patent/KR20220148823A/ko active Pending
- 2021-02-02 MX MX2022009200A patent/MX2022009200A/es unknown
- 2021-02-02 JP JP2022547055A patent/JP2023512294A/ja active Pending
- 2021-02-02 WO PCT/US2021/016247 patent/WO2021158565A2/en not_active Ceased
- 2021-02-02 CA CA3168836A patent/CA3168836A1/en active Pending
- 2021-02-02 IL IL294926A patent/IL294926A/en unknown
-
2025
- 2025-12-24 AU AU2025287330A patent/AU2025287330A1/en active Pending
-
2026
- 2026-03-04 JP JP2026033811A patent/JP2026094336A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4527933A1 (en) | Dual-carrier system for treating hearing damage, and use thereof | |
| JP2026041921A5 (enExample) | ||
| WO2024015510A1 (en) | Sars-cov-2 lacking the envelope protein as an attenuated vaccine virus against covid-19 | |
| JP7092663B2 (ja) | 組換えオルフウイルスベクター | |
| CN110036020A (zh) | 具有狂犬病病毒抗原的黑猩猩腺病毒构建体 | |
| JP2023526073A5 (enExample) | ||
| JP2537345B2 (ja) | 狂犬病に対するワクチン及びその製造法 | |
| US12180512B2 (en) | Simian adenoviral vectors with two expression cassettes | |
| CN110741080A (zh) | 多转基因重组腺病毒 | |
| AU2025287330A1 (en) | Poxvirus-based vectors produced by natural or synthetic DNA and uses thereof | |
| AU2022338199A1 (en) | Utilization of micro-rna for downregulation of cytotoxic transgene expression by modified vaccinia virus ankara (mva) | |
| JP2020537525A (ja) | 複製能力のあるアデノウイルスベクター | |
| JP2022511227A (ja) | Ｉｇｆ－１異型体を発現させるｄｎａコンストラクトを用いた神経病症の治療 | |
| EP3697919A1 (en) | Adenoviral vectors with two expression cassettes encoding rsv antigenic proteins or fragments thereof | |
| Lundstrom | Application of viruses for gene therapy and vaccine development | |
| EP4368203A1 (en) | Construction and use of anti-vegf antibody in-vivo expression system | |
| CN102086453B (zh) | 以粘蛋白1和生存素为靶点的肿瘤dna疫苗及病毒载体疫苗 | |
| CN118345117A (zh) | 重组腺相关病毒大基因包装表达载体的构建生产和用途 | |
| WO2006002594A1 (en) | A recombinant canine adenovirus type-2 and the preparation method and usage thereof | |
| KR101420564B1 (ko) | ＴＧＦ－β２ 발현을 억제하는 ｓｈＲＮＡ | |
| CN102892428A (zh) | 表达兔出血热病毒的vp60主要衣壳蛋白的副痘病毒 | |
| CN105879060A (zh) | 成纤维激活蛋白α为靶点的肿瘤DNA疫苗及病毒载体疫苗 | |
| US20250235527A1 (en) | Synthetic modified vaccinia ankara (smva) based coronavirus vaccines | |
| US20230097513A1 (en) | Poxvirus-based vectors produced by natural or synthetic dna and uses thereof | |
| JP2022508835A5 (enExample) |